FDA — authorised 30 August 2018
- Application: NDA210807
- Marketing authorisation holder: MSD MERCK CO
- Status: supplemented
FDA authorised Delstrigo on 30 August 2018
Yes. FDA authorised it on 30 August 2018; FDA has authorised it.
MSD MERCK CO holds the US marketing authorisation.